Results 1 - 10 of 3110 : 1 2 3 4 5 6 7 8 9 Next
Get RSS Feed for Multinational Company
The Dow's 3 Biggest Losers This Week
Here they are.
Why the Dow Finished Higher This Week, and Facebook Didn't
An interesting week ends with the Dow slightly in the black.
Have J&J's Approval Hopes Vanished?
Johnson & Johnson might have trouble sidestepping the competition.
The Meaningless Drug Approval That Could Cost the Industry Billions
Being able to use surrogate endpoints is important for drug developers.
Why These 3 Dow Stocks Surged Today
Here they are.
Chelsea gets updated information from the FDA.
That's what phase 2 trials are for.